• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Orchid Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3135.0
  • ISIN : INE191A01027
628.75 -7 (-1.07%)
  • As on 31 May 2025 (EOD)

  • Today’s Low

    603.80

  • Today’s High

    641.10

  • Open

    603.80

  • Perv Close

    635.55

  • 52W Low

    603.80

  • 52W High

    1,997.40

Key Indicators

  • P/E(TTM)

    30.05

  • Mar.Cap (₹Cr.)

    3,188.96

  • Div & Yield %

    0.00

  • Book Value(₹)

    261.06

  • Debt-Equity Ratio

    -1.07

  • AGM Date

    30-May-2025

  • EPS

    20.99

  • P/E Ratio

    30.05

Financials Ratios

  • Debt-Equity Ratio

    0.25

  • Mar.Cap (₹Cr.)

    3,188.96

  • RONW (%)

    3.02

  • ROCE (%)

    3.20

Score Board

  • Equity (₹ in Cr.)

    50.72

  • BV (₹)

    261.10

  • Sales( ₹ in Cr.)

    921.93

  • NP (in Cr.)

    106.48

  • NP Var(%)

    12.0

  • Div%

    0.0

  • CPS (₹)

    27.80

  • EPS (₹)

    21.00

  • Traded Value (₹ in Lakhs)

    3,199.36

  • 52 Week High

    1,997.40

  • 52 Week Low

    603.80

  • Price BSE

    631.0

  • Price NSE

    629.00

  • Market Capital( in Cr.)

    3,199.36

  • P/C Ratio

    22.70

  • P/E Ratio

    30.10

  • Price Vs.BV

    21.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 819.37 665.90 556.97 450.70 481.21 583.65
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 819.37 665.90 556.97 450.70 481.21 583.65
Other Income 30.39 58.64 56.97 6.46 24.28 217.86
Stock Adjustments 43.89 21.48 22.73 15.69 20.07 -20.43
Total Income 893.65 746.02 636.67 472.85 525.56 781.08
EXPENDITURE :            
Raw Materials 528.35 406.10 336.80 244.96 220.38 257.73
Power and Fuel Cost 62.92 61.26 52.74 39.31 47.44 48.76
Employee Cost 69.64 65.35 60.21 64.40 71.60 79.14
Other Manufacturing Expenses 32.65 29.19 26.26 24.26 40.77 41.85
Selling and Administration Expenses 53.17 34.96 37.77 31.58 58.78 48.39
Miscellaneous Expenses 5.46 7.28 7.22 24.38 112.29 269.63
Employee Benefit Expenses 69.64 65.35 60.21 64.40 71.60 79.14
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 752.20 604.14 521.00 428.89 551.26 745.51
Operating Profit 141.45 141.88 115.67 43.96 -25.71 35.55
Interest 16.71 32.90 33.46 52.21 6.22 6.68
Gross Profit 124.74 108.98 82.21 -8.25 -31.93 28.87
Depreciation 33.22 54.79 87.02 108.90 117.91 129.92
Profit Before Tax 91.52 54.19 -4.81 -117.15 -149.84 -101.05
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -3.23 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 94.75 54.19 -4.81 -117.15 -149.84 -101.05
Extraordinary Items -0.19 40.00 0.51 0.98 0.09 24.94
Adjusted Net Profit 94.94 14.19 -5.32 -118.13 -149.93 -125.99
Adjustment below Net Profit 0.00 0.00 0.00 0.00 88.56 0.00
P & L Balance brought forward -2,082.68 -2,136.64 -2,133.29 -2,016.74 -1,953.57 -1,853.42
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.45 0.23 -1.46 -0.60 1.89 -0.90
P & L Balance carried down -1,988.38 -2,082.68 -2,136.64 -2,133.29 -2,016.74 -1,953.57
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 18.68 13.28 -1.18 -28.70 -36.71 -11.36
Earnings Per Share(Adj)-Unit Curr 18.68 13.28 -1.18 -28.70 - -11.36
Book Value 226.69 162.53 149.30 150.13 178.67 -84.86
Book Value(Adj)-Unit Curr 226.69 162.53 149.30 150.13 - -84.86

Shareholding Pattern

  • Promoter Group

    69.84%

  • Public Share Holding

    30.16%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 35,419,957 69.84 35,419,957 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 35,419,957 69.84 35,419,957 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 32,440 0.06 32,440 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,364,560 2.69 1,364,560 67
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 305,891 0.60 305,891 4
Mutual Funds / UTI 9,527,890 18.79 9,527,890 16
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 327,308 0.65 327,308 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 11,558,089 22.79 11,558,089 94
2] Non Institution
Bodies Corporate 682,077 1.34 678,839 383
Clearing Members 4,142 0.01 4,142 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 197,596 0.39 197,596 641
Foreign Non Institution Other 68 0.00 68 1
Hindu Undivided Families 140,755 0.28 140,755 956
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 322,128 0.64 322,128 10
Individuals holding nominal share capital up to Rs. 1 lakh 2,267,927 4.47 2,267,653 32,205
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 125,730 0.25 125,730 5
Others 636 0.00 636 3
Sub Total 3,741,059 7.38 3,737,547 34,208
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 50,719,105 100.00 50,715,593 34,303

Company Background

Orchid Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Orchid Pharma Ltd
  • BSE Code : 3135.0
  • ISIN : INE191A01027

  • Incorporation Year

    1992

  • Registered Office

    Orchid Towers Nungambakkam
    313 Valluvar Kottam High Road, Chennai,
    Tamil Nadu-600034

  • Telephone

    91-44-28211000/28230000

  • FAX

    91-44-28211002

  • Chairman

    Ram Gopal Agarwal

  • Managing Director

    Manish Dhanuka

  • Company Secretary

  • Auditor

    Singhi & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar


    ,
    ,
    Mumbai -

Orchid Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Orchid Pharma 630.80 849.76 819.37 30.05 3.33
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92